Trial Profile
Open-label multi-center safety trial of fentanyl sublingual spray (fentanyl SL spray) for the treatment of breakthrough cancer pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions
- Sponsors INSYS Therapeutics, Inc
- 23 Mar 2012 Additional lead trial investigator (Larry Dillaha) identified as reported by ClinicalTrials.gov.
- 23 Mar 2012 Additional lead trial investigator (Larry Dillaha) identified as reported by ClinicalTrials.gov.
- 03 Jun 2011 Actual end date changed from Nov 2007 to Dec 2007 as reported by ClinicalTrials.gov.